The ICON Study: Outcomes After FMT for Patients With IBD and CDI
Status:
Completed
Trial end date:
2020-12-31
Target enrollment:
Participant gender:
Summary
In this study the investigators will evaluate patients with IBD and and at least 2 confirmed
c.difficile infections who will be undergoing FMT. The investigators will assess patients
before FMT and then follow patients prospectively post FMT at week 1, 8 and 12 to assess for
recurrence of c.difficile infection and IBD outcomes.
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
Brigham and Women's Hospital
Collaborators:
Icahn School of Medicine at Mount Sinai Indiana University The Miriam Hospital